Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment-Reference-Cited by-同舟云学术

Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment

Published:2014-04-21 Issue:5 Volume:29 Page:1028-1034
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Seto Wai-Kay¹,Lam Yuk-Fai¹,Fung James¹²,Wong Danny Ka-Ho¹²,Huang Fung-Yu¹,Hung Ivan Fan-Ngai¹,Lai Ching-Lung¹²,Yuen Man-Fung¹²

Affiliation:

1. Department of Medicine; the University of Hong Kong; Queen Mary Hospital; Hong Kong

2. State Key Laboratory for Liver Research; the University of Hong Kong; Queen Mary Hospital; Hong Kong

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12476/fullpdf

Reference31 articles.

1. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N. Engl. J. Med.,2004

2. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease;Yuen;Antivir. Ther.,2007

3. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B;Lai;N. Engl. J. Med.,2006

4. Three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients: viral suppression, viral resistance, and clinical safety;Yuen;Am. J. Gastroenterol.,2011

5. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B;Chang;Hepatology,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review;Viruses;2023-12-08

2. The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trial;Trials;2023-12-02

3. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection;Biomedicines;2023-07-08

4. Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis;JHEP Reports;2023-06

5. Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study;Frontiers in Pharmacology;2023-06-01